Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), The Home ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 5 years ago, it would be worth $5,817.45 today based on a price of $823.28 for LLY at the time of writing.

Korean officials discovered the painting in the Smart Museum’s collection at the University of Chicago. It was stolen from a ...

Eli Lilly & Co. and health tech company Kalderos Inc. are seeking to revive lawsuits in the DC Circuit after a federal judge ...

Women with migraine who are planning a pregnancy or become pregnant do not need to be medication-free, according to a ...

Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...

Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...